chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 9.0
Sex: F
Vaccine: FLU3, VARCEL
Symptoms: Injection site erythema, Injection site oedema, Injection site pain
Clinical narrative: Information has been received from a physician concerning a 9 year old female who on 09-JUL-1999 was vaccinated with a first dose of VARIVAX (Oka/Merck). At 10:30am 18-OCT-2007, the patient was vaccinated in the right arm with a second dose of VARIVAX (lot # 656287/1508F) with diluent (lot # 3013U). Concomitant therapy included FLUZONE which was vaccinated in the left arm at the same time. On 19-OCT-2007, the patient experienced erythema measuring 4.5 cm in diameter and pain at the injection site of VARIVAX (Oka/Merck) on the right arm, and mild edema was also noted. The physician was contacted. On an unspecified date the patient was treated with cold compresses and BENADRYL for itch if any. On 22-OCT-2007, the patient recovered. This is one of several reports from the same source. No further information was available.
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a physician concerning a 9 year old male who on 01-MAY-2000 was vaccinated with a first dose of VARIVAX. At 9:50 am on 26-SEP-2008, the patient was vaccinated in the left arm with a second dose of VARIVAX (lot # 661645/0972X) with diluent (lot # 4017X). Illness at time of vaccination included insect bite and furuncle in the left thigh. Concomitant therapy included FLUMIST in the nasal at the same time. On 27-SEP-2008, the patient experienced red and swelling at injection site on the left arm measuring over 3.5 inches 2.5 inches. The area was warm to touch. The patient had no respiratory difficulty. The patient complained of tenderness at the injection site. On unspecified date the patient was treated with Benadryl, oral administration, per 6 hours and cool compresses to injection site. Subsequently, the patient had a trace of red area and monitored for swelling and redness. On 29-SEP-2008, the patient recovered. This is one of several reports from the same source. No further information is available.
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site reaction, Injection site swelling
Clinical narrative: Information has been received from a physician concerning a 9 year old male with rhinitis allergic who on 08-OCT-1999 was vaccinated with a first dose of VARIVAX (Oka/Merck). On 30-JUN-2008 the patient was vaccinated with a second dose of VARIVAX (Oka/Merck) (The lot # is reported as 659948/1851U). Concomitant therapy included CLARITIN. Two days later on 02-JUL-2008, the patient experienced an injection site reaction of not a very large raised area as the physician believes this is because the patient was also taking  loratadine for allergic rhinitis. No reaction was reported after the first dose of VARIVAX. The patient had contacted the physician. Subsequently, the patient recovered on unspecified date. This is one of several reports from the same source. Additional information has been requested. Follow up information has been received from a health professional concerning a 9 year old male patient with rhinitis allergic and cough who on 30-JUN-2008 at 09:45 was vaccinated with second dose of VARIVAX (Oka/Merck) (Lot  # 659948/1851U) in the arm. Concomitant therapy included CLARITIN. On 01-JUL-2008 the patient experienced redness and swelling at the injection site. Size was about half dollar size. The patient use cool compress and BENADRYL. for swelling/itch. On 04-JUL-2008 the patient was recovered. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Herpes zoster, Pain
Clinical narrative: Information has been received from a physician concerning a child (age unknown) who was vaccinated with the first and second 0.5 ml doses of VARIVAX on 02-NOV-1995 and 28-SEP-2007 respectively. Approximately 1 year after receiving the second dose of VARIVAX, the patient was diagnosed with shingles on 13-JUN-2008. The patient sought unspecified medical attention. At the time of the report, the outcome of shingles was unknown. Follow-up information has been received from a physician who reported that the patient received the first and second 0.5 ml doses of VARIVAX on 02-NOV-1995 and 28-SEP-2007. It was reported that the herpes zoster began on 13-OCT-2008. There was no recent exposure to chickenpox or shingles. The maximum temperature of the patient reported as 98 Fahrenheit. The patient reported pain of a 4 on a scale of 1 to 10. No additional information was available. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Injection site pruritus, Injection site rash, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a nurse practitioner concerning a female with allergy to "6MP" and CHRON'S disease who on 02-OCT-2008 received the first dose of VARIVAX (Oka/Merck) (lot# 659068/0394X), 0.5ml, subcutaneously in her left arm. Concomitant therapy included CIPRO. Subsequently the patient experienced rash at the injection site with itching and what "appears to be 1 pox". The patient sought medical attention. Additional information has been requested.
Age: 34.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from consumer, for the Pregnancy Registry for VARIVAX (Oka/Merck), concerning a 34 year old female who in January 2007, was vaccinated with the first dose of VARIVAX (Oka/Merck) and a booster in February 2007 and then she got pregnant 3 months after that. When after the pregnancy the physician did a titer test to check if she built up the immunity for the vaccine it came out as non detectible (0.474 ADIGG and 0.5ABIGM). The patient went ahead and got another VARIVAX vaccine (Oka/Merck) dose a week ago (approximately 07-OCT-2008). There was no concomitant medication. The patient sought medical attention. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Injection site cellulitis, Injection site erythema, Injection site swelling
Clinical narrative: Information hs been received from a physician and a licensed practical nurse concerning a female patient who was recently vaccinated with the second dose of VARIVAX (Oka/Merck). Subsequently the patient experienced redness at the injection site, swelling at the injection site and cellulitis. At the time of the report the patient had recovered from the redness and swelling at the injection site. The patient sought unspecified medical attention. This is one of several reports received from the same source. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information hs been received from a physician and a licensed practical nurse, concerning a 14 year old female patient with no pertinent medical history, allergies or drug reactions, who on 18-SEP-2008 was vaccinated with the second dose of VARIVAX (Oka/Merck) (lot #0996), subcutaneously in her left arm, at 4:00pm. The physician reported that the patient experienced injection site reaction after receiving the vaccine; on follow-up, the nurse reported that on 09-SEP-2008 the patient experienced redness and swelling at injection site. No laboratory diagnostic studies were performed. At the time of the report the patient had recovered. The patient sought unspecified medical attention. There were no illnesses at time of vaccination. This is one of several reports received from the same source. No further information is available.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered medical assistant concerning a 4 year old male who was vaccinated with VARIVAX (route not reported) on an unspecified date. Subsequently the patient developed chickenpox. The date of the onset of the chickenpox. No further information is available.
Age: 74.0
Sex: U
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a patient who on 16-OCT-2008 was vaccinated with VARIVAX (Merck) (LOT# 660897/0788X) instead of ZOSTAVAX (Merck). No adverse event complaints at this time. It was not reported whether the patient sought medical attention. Additional information was received from the nurse stating that vaccination error was human mistake- she was exhausted and pulled the wrong vaccine. Further information has been requested.
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash erythematous, Rash pruritic, Varicella post vaccine, Viral DNA test negative
Clinical narrative: Information has been received from a pharmacist concerning a 9 year old female who on an unspecified date was vaccinated with a dose of VARIVAX. "Three weeks post vaccination with VARIVAX," the patient started to develop pox on legs (20 pox), arms (5 pox) and head (3 pox). The pox were described as "larger mosquito bites" that were red and itchy. The patient contacted the pharmacist. The pharmacist considered this atypical breakthrough since none of the pox was on the trunk. At the time of the report, 30-OCT-2008, the patient had not recovered from the pox. The patient was enrolled in the Varicella Zoster Virus Identification Program to identify if VZV is present and if it is present to identify if it is associated with the wild-type VZV strain or with OKA/Merck vaccine VZV strain. Follow-up information was received on 14-NOV-2008 from the pharmacist indicating that on 17-SEP-2008, the 9 year old female patient with no past medical history or allergies was vaccination in the left arm with a first dose of VARIVAX. There was no concomitant medication. The patient had no recent exposure to chickenpox or shingles. It was reported that the patient developed 35 lesions on legs, arms and head. Two samples of the lesion were collected from the vesicle on 31-OCT-2008. The PCR results revealed inadequate specimen, negative for B-globin, no strain identification. It was reported that the patient had recovered from the events. Follow-up information was received on 20-NOV-2008 via phone call from the pharmacist who reported that the patient's rash was an unusual rash due to the distribution on her legs, arms and head. He also reported that the rash had cleared. Additional information is not expected.
Age: 1.3
Sex: M
Vaccine: FLU3, HEPA, PNC, VARCEL
Symptoms: Injection site vesicles
Clinical narrative: Initial and follow-up Information has been received from a nurse practitioner, concerning a 15-month-old male infant with eczema, who on 20-OCT-2008 received the first dose of 0.5 ml VARIVAX (Merck) (lot # 661661/0995X) via subcutaneous route on his right leg. Concomitant vaccinations included the fourth dose of PREVNAR (lot # C68312) IM in the left leg, the first dose of HAVRIX (lot # B257AA) IM in the right leg, and the first dose of FLUZONE (lot # UT2787AA) IM in the left leg. On 30-OCT-2008 (previously reported as 29-OCT-2008), 10 days post vaccination, the patient presented at office with 3 "reddish yellow" vesicles on his leg around the injection site. His mother was advised to give him BENADRYL PRN. At the time of reporting, the patient's outcome was unknown. Additional information is not expected.
Age: 42.0
Sex: F
Vaccine: TYP, VARCEL, YF
Symptoms: Pyrexia, Rash vesicular
Clinical narrative: Initial and follow up information has been received from a nurse concerning a 43 year old female with history of fever with previously vaccinations with yellow fever and tetanus, no known medication allergies, no known illness at the time of vaccination, who on 15-AUG-2008 was vaccinated at a travel clinic with a first dose of VARIVAX (Oka/Merck); lot # 658587/1520U; 0.5 mL subcutaneously. On 15-AUG-2008, concomitant vaccination included a dose of TYPHIM VI (Lot no. B0347) and a dose of yellow fever virus vaccine (Lot no UF426AA). About 7 days after vaccination, on approximately 22-AUG-2008, the patient complained of varicella type rash on her foot and scalp as well as a low grade fever. There were no lab diagnostic studies performed. On an unknown date the patient had recovered. The nurse reported that the patient was not seen by a physician, but she consulted by phone. On an unknown day, the second dose of VARIVAX vaccine (Oka/Merck) was given to the patient with no post symptoms. No further information is available.
Sex: U
Vaccine: VARCEL
Symptoms: Antibody test negative, Varicella zoster serology negative
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a patient who was vaccinated with a dose of VARIVAX (Merck) (lot # not reported). Subsequently the patient experienced negative titer. Patient is asymptomatic. Patient sought medical attention, and not recovered at the time of reporting. Additional information is not expected.
Age: 2.0
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a nurse concerning a 24 month old patient with no pertinent medical history who on 03-APR-2007 was vaccinated with a first dose of VARIVAX (Oka/Merck) (lot # 656174/1500F) 0.5 mL subcutaneously. there was no concomitant medication. The nurse reported that on 30-SEP-2008 the patient developed "active chickenpox". At time of reporting, the patient had recovered. The patient sought unspecified medical attention. There were no lab diagnostics studies performed. This is one of two reports from the same source. Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Lymphadenopathy, Rash maculo-papular, Rash vesicular, Scab, Viral infection
Clinical narrative: Information has been received from a physician concerning a 11 year old male with no past medical history of immunocompromise or immunosuppressive therapy and otherwise healthy who on 21-SEP-1998 was vaccinated with the first dose of VARIVAX (Oka/Merck). The patient received his second dose of VARIVAX (Oka/Merck) on 15-OCT-2008. The patient was also received BOOSTRIX and MENACTRA on 15-OCT-2008. Twenty-four hours later (the following day), the patient developed a maculopapular rash on the face with  few lesions, two scabbed lesion on scalp, lesions behind ear, upper chest, torso and thighs. Lesions were maculopapular. Some with halo effect. Patient also had some post auricular lymphadenopathy on the left side. The mother of the patient called and stated that her son had more lesions and some "have water in them" on 17-OCT-2008. The patient sought medical attention at the physician's office at 2PM on 17-OCT-2008. The physician noted a normal throat. The patient was afebrile and initially diagnosed with a viral illness. The physician also noted that the patient had exposure to a schoolmate who had a rash on the face. The school nurse could not role out Varicella. At the time of the reporting, the patient had not recovered from the adverse experiences. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Initial and follow-up information have been received from a register nurse concerning a 7 year old female student with no allergies and no pertinent medical history who on 17-MAY-2002 was vaccinated with the first dose of VARIVAX (Merck) SC 0.5 ml (lot # 635791/0203M). Secondary suspect therapy included the second dose of PROQUAD (Merck) (lot # 655267/0971F) SC on 26-SEP-2006. Concomitant therapy included the 5th dose of DTaP IM (lot # C2489AN) and the 4th dose of polio SC (lot # 200L8) on 26-SEP-2006. On 30-OCT-2008 (also reported as 29-OCT-2008) the patient presented with 15 insect-like lesions on her chest and abdomen and developed chickenpox. The patient was being treated with BENADRYL. On an unspecified date the patient recovered from chickenpox. The patient sought medical attention and came into the office on 30-OCT-2008. Additional information is not expected.
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a registered nurse concerning a 9 year old female who was vaccinated with VARIVAX (Oka/Merck) intradermally. The patient developed redness and swelling at the injection site on her right forearm. The patient's redness and swelling at the injection site persisted. The patient sought medical attention and visited to school nurse. This is one of several reports from the same source. Additional information has been requested.
Age: 7.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a healthcare professional concerning her daughter who in 1996 was vaccinated with VARIVAX (Merck). The patient was 6 or 7 year old when she received the vaccination. The patient got a bad case of chickenpox after she got the vaccine. The patient was treated with home remedies like baths and things like that. She did recovered. It was not considered life threatening. The reporter did not remember the doctor's name. No further information is available.
Sex: M
Vaccine: VARCEL
Clinical narrative: Information has been received from a nurse concerning a male who on 07-MAR-2001 was vaccinated with a first dose of VARIVAX (Merck) 0.5 mL subcutaneously. On 07-JUL-2008, the patient received a second dose of VARIVAX (Merck) 0.5 mL subcutaneously. The nurse stated that in "early October" 2008 the patient was exposed to chickenpox and later, on 15-OCT-2008 was diagnosed with chickenpox. The patient sought unspecified medical attention. This is one of two reports from the same source. Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: VARCEL
Symptoms: Culture positive, Rash pustular
Clinical narrative: Information has been received from a healthcare worker concerning a 12 year old male with no relevant medical history or allergies, who on 22-APR-1997 was vaccinated with a first dose of VARIVAX (Merck) (lot number, injection site and route not reported). On 28-JUN-2008 the patient was vaccinated subcutaneously with a second dose of VARIVAX (Merck) (lot number 653306/0674U) (injection site not reported). There was no concomitant medication. On 28-OCT-2008 the patient experienced chickenpox. The patient had about 25-30 lesions on his face, back and trunk. The patient went to see the physician's at the office. At time of this report, the patient was recovering from the event. Follow-up information was received from the healthcare worker who reported that the patient received the second dose of VARIVAX (Merck) in the left arm. On 28-OCT-2008 the patient developed 25 to 30 spots on his face, back and trunk. The healthcare worker also reported that the patient had one pustule in the right leg which was cultured and sent out. The patient was given clindamycin. Laboratory test included culture results showed light growth staphylococcus. The healthcare worker also reported that the patient had recovered from the events. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Allergy test, Hypersensitivity
Clinical narrative: Information has been received from a allergist concerning a patient who in 2007. also reported as last year, was vaccinated with a dose of VARIVAX (Oka/Merck) (lot number, injection site and route not reported).  Subsequently in 2007, also reported as last year, the patient developed an allergic reaction.  The patient went to the allergist's office and got tested for allergy.  The outcome of the patient's experience was unknown.  No further information is available.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site urticaria
Clinical narrative: Information has been received from a healthcare professional concerning a 12 month old female who on 16-OCT-2008 was vaccinated subcutaneously with a dose VARIVAX (Merck) (lot number 661642/1153X) in the left arm. On 30-OCT-2008 the patient's injection site had a raised welt as the size of a pencil tip with no pain and no itching. It was unknown if the patient sought any medical attention. The outcome of the patient's event was unknown. Additional information is not expected.
Age: 73.0
Sex: M
Vaccine: VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Initial and follow-up information has been received from a registered nurse and a physician concerning a 73 year old female patient who on 05-SEP-2008 was vaccinated with a dose of VARIVAX (Oka/Merck) in the left deltoid (lot number reported as 662970/1207X, which is a validated lot number for ZOSTAVAX (Oka/Merck) not VARIVAX (Oka/Merck) (injection route not reported). On 07-Oct-2008 the patient was inadvertently vaccinated with a second dose of VARIVAX (Oka/Merck) (lot number also reported as 662970/1270X) (injection site and route not reported). It was reported that the patient was supposed to receive ZOSTAVAX (Oka/Merck) (MSD). The patient had not experienced any known symptoms. Additional information is not expected.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Pyrexia, Rash generalised
Clinical narrative: Information has been received from a caller concerning her 12 month daughter with food allergies and no pertinent medical history, on 03-JUL-2007 was given her first dose of PEDVAXHIB, who on 01-MAY-2008 was vaccinated with VARIVAX (Merck) (caller did not know if it was VARIVAX (Merck) or not). The caller stated that after her daughter was vaccinated with VARIVAX (Merck) her daughter developed low grade fever and a rash that started on her leg and moved over her body. On 27-AUG-2008, the patient was given her second dose of PEDVAXHIB. The patient sought unspecified medical attention, no lab diagnostics studies performed. Additional information has been requested.
Age: 1.4
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Herpes zoster, Virus culture
Clinical narrative: Information has been received from a nurse concerning a 22 month old male who on 06-MAY-2008 was vaccinated with a dose of VARIVAX (Merck) (lot number, injection site and route not reported) and a dose of MMR (MSD). On approximately 30-OCT-2008, also reported as 4 days ago and late October 2008, the patient developed rash. The rash covered the right leg (upper thigh) and buttocks. On 03-NOV-2008, the patient was seen in the office and was diagnosed with shingles. Laboratory test included culture (result unspecified). The patient's shingles persisted. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a pharmacist and nurse midwife concerning an adult female who was vaccinated with a dose of VARIVAX (Merck) (lot number unknown) and developed a mild varicella rash after administration of the vaccine. No further information was available.
Age: 33.0
Sex: F
Vaccine: VARCEL
Symptoms: Biopsy site unspecified normal, Herpes simplex serology negative, Pityriasis lichenoides et varioliformis acuta, Rash generalised, Scab
Clinical narrative: Information has been received from a physician concerning a 33 year old female pregnant (17 weeks) patient with a history of VARICELLA at age of 11.  On an unknown date, the patient's son was vaccinated at age of 7 months with VARIVAX (Oka/Merck).  The physician reported that 19-OCT-2008 the patient developed a generalized rash involving her abdomen (bilateral), neck and hands.  No rash on face or scalp.  It was reported that there was never a ZOZTERIFORM distribution, so if it was ZOSTER, it was generalized and began that way.  It was reported that the patient had been seen by 4 dermatologists and the leading clinical diagnosis by them was ZOSTER.  The physician felt that the patient's rash was not typical of VARICELLA, mainly because of the odd distribution.  The patient's rash was not typical of VARICELLA, mainly because of the odd distribution.  The patient's lesions were not typical either.  The physician thought it was a rickesttsial infection.  A culture of HSV was performed and the result was negative.  Several biopsies were made and they didn't seem to be characteristic of anything.  The patient was enrolled in the VARICELLA ZOSTER Virus Identification Program to identify if VZV is present and if it is present to identify if it is associated wit the wild-type (WT) VZV strain or with the OKA/Merck vaccine VZV strain.  Follow-up information was received with reported that there was odd looking "scabs" on the patient.  The sample was inadequate.  Follow up information was received through the VARICELLA ZOSTER Virus (VZV) identification program.  On 31-OCT-2008 a sample was collected for PCR but was INADEQUATE and no strain was identified.  On 14-NOV-2008, the patient was seen by other physician and all lesions was resolving.  The physician diagnosed Mucha-Habermann disease, a parapsoriasis of unknown cause.  The physician requested a biopsy that showed giant cells, not multinucleated.  The physician did not think this is a disease of pregnancy.  This is one of 2 reports from the same source.  Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Antibody test negative, Varicella zoster serology negative
Clinical narrative: Information has been received from a physician concerning a 7 year old male with hypersensitivity and asthma and a history of eczema who on 11-OCT-2002 was vaccinated with the first dose of VARIVAX (Merck) (lot #643092/0551M) by SQ. Concomitant therapy included inhaled corticosteroid (unspecified), unspecified bronchodilator and cough, cold, and flu therapies (unspecified). Subsequently full panel including VZV titer confirmed that the patient did not seroconvert. On 24-Mar-2004, the patient received the second dose of VARIVAX (Merck) (lot #647709/1247N) by SQ. The patient sought medical attention for his experience. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a female patient who in April 2007, was vaccinated with a dose of VARIVAX (Merck) (Lot # 645579/0440N) and developed a chicken pox rash as per the father's report.  The registered nurse reported the patient had not been by the physician and no follow up appointment is scheduled.  At the time of reporting the patient was recovering from "chicken pox rash".  The registered nurse mentioned that the patient received MMRII + VARIVAX (Merck) (Lot # 656941/0227U) on 15-AUG-2003 without any incidence.  It was reported that the patient sought for medical attention by a phone call.  Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Urticaria, Varicella zoster virus serology positive
Clinical narrative: Information has been received from a licensed practical nurse concerning a 5 year old male patient, with no known pertinent medical history, or no known drug reaction/allergies, who on 18-JUN-1997 was vaccinated with the first dose of VARIVAX (Merck) (Lot No 622969/0423E) 0.5 ml, subcutaneous.  The licensed practical nurse reported that on an unknown date, after the vaccination the patient developed hives soon all over his body.  The licensed practical nurse reported that the patient's mother did not tell the patient's primary care physician, until recently when the patient was scheduled to receive the second dose.  The licensed practical nurse reported that the second dose had not been administered.  There was no mention that this was a chickenpox outbreak, rather it was hives.  The licensed practical nurse believed that when the patient had hives, the on-call physician was seen.  On an unknown date the patient had recovered.  Follow up information has been received from the licensed practical nurse, which reported that the male patient, on 18-JUN-1997, developed hives 1 hour after vaccination, approximately after 5:00 pm, with VARIVAX.  The doctor on call was called.  It was questioned whether the patient should receive the second dose of VARIVAX (Merck).  On 10-NOV-2008 a Varicella Zoster IGG test (HVZG and HVZM) was performed and the titer drawn was 6.58 (greater than 1.10 = positive IgG antibody to varicella.  Additional information has been requested.
Age: 64.0
Sex: U
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information hs been received from a registered nurse concerning a 64 year old patient who on approximately 01-NOV-2008 was vaccinated with VARIVAX (Oka/Merck), instead of ZOSTAVAX (Oka/Merck) (duration and dose not reported). No symptoms reported. Additional information hs been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a physician concerning a patient who on an unspecified date was vaccinated with the first dose of VARIVAX (Oka/Merck). Subsequently, the patient developed a mild varicella-like rash. It is unknown if the patient sought medical attention. At the time of reporting, the outcome was unknown. No further information is available.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered school nurse concerning an 8 year old female patient with a history of shingles (2006) and lesions on chest at time of vaccination, who on 02-JUL-2001 was vaccinated with the first dose of VARIVAX (Oka/Merck) (Lot # 638566/1886K) possibly in the right arm. On 14-OCT-2008, the patient was diagnosed with varicella. On 14-OCT-2008 was performed an exam at pediatrician office (results not provided). The patient sought medical attention by doctor visit. The patient's varicella was currently ongoing. Additional information has been requested.
Age: 7.0
Sex: F
Vaccine: VARCEL
Symptoms: Cellulitis
Clinical narrative: Information has been received from a physician concerning a 7 year old female who on 03-NOV-2008 was vaccinated with the second dose of VARIVAX (Oka/Merck) (lot no. 661662/1137X) (route and site not reported). Concomitant therapy included influenza virus vaccine (unspecified). On 04-NOV-2008 the patient experienced cellulitis. Additional information has been requested.
Age: 16.0
Sex: M
Vaccine: FLU3, VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a physician concerning a 16 year old male with no pertinent medical history who on 03-JUN-1998 was vaccinated with a first dose of VARIVAX subcutaneously.  On 03-NOV-2008 was vaccinated with a second dose of VARIVAX (Merck) (lot # 661856/1222X) 0.5 mL, subcutaneously.  There was no concomitant medication.  On 04-NOV-2008 the patient experienced an injection site reaction.  The patient experienced a rash that was itchy, red, swollen, and warm to the touch.  At time of reporting, the patient was recovering.  The patient sought medical attention and saw the physician.  In follow-up information, the physician reported that on 03-NOV-2008 the patient received a dose of FLUZONE IM (lot # 02769AA).  The physician reported that the patient's adverse events occurred on his right arm.  The patient recovered on 07-NOV-2008.  The patient had no illness at time of vaccination.  The patient also had an adverse reaction after vaccination with hepatitis B virus vaccine rHBsAg (yeast) (manufacturer unknown) (WAES # 0812USA00480).  No further information is available.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has not been received from a nurse concerning a 24 month old female who on 15-OCT-2007 was vaccinated with VARIVAX (Oka/Merck) (lot # 658588/1273U). There was no concomitant medication. No medical history or drug allergy was reported. On approximately 15-OCT-2008 the patient experienced breakthrough varicella on lower back and arms and was seen in the office on 20-OCT-2008. No treatment was required. The patient's breakthrough varicella on her lower back and arms persisted. Additional information has been requested.
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received regarding a case in litigation from a registered nurse concerning a 9 year old female who on 25-SEP-2008 was vaccinated with a dose of VARIVAX (Oka/Merck) (injection site and route not reported). Subsequently the patient was diagnosed with shingles. The patient was receiving treatment from a physician. At time of this report, the patient was recovering from shingles. Additional information has been requested.
Age: 7.0
Sex: F
Vaccine: FLUX, HEPA, VARCEL
Symptoms: Dermatitis contact, Rash maculo-papular, Rash pruritic, Rash pustular
Clinical narrative: Information has been received concerning a 7 year old female with no concurrent conditions or pertinent medical history who on 28-OCT-2008 received a booster of VARIVAX vaccine (Oka/Merck). Concomitant therapy included influenza virus vaccine (unspecified) and hepatitis A virus vaccine (unspecified). On 31-OCT-2008 was noticed 5-6 pustular lesions on chest. On 03-NOV-2008 through 05-NOV-2008 noticed increasing maculopapular rash on chest and some small areas on back. One lesion upper arm. Nothing on face, neck, legs. No fever or any other complaints. Rash itchy, but no painful. The patient sought medical attention. On 5-NOV-2008 the primary pediatrician felt that it was not varicella, possibly shingles- although it crossed dermatomes. The patient was referred to a dermatologist. On 06-NOV-2008 the first dermatologist felt it was shingles, although when another dermatologist was consulted at the same appointment, the patient was diagnosed with poison ivy. The outcome of the patient was not reported. Follow up information was received from the medical assistant who stated that the patient did not have an adverse effect from VARIVAX (Merck). It was determined that the patient had poison ivy. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received form a registered nurse concerning a 12 year old female with ZITHROMAX allergy (total body swelling) and no illness at the time of vaccination who on 10-NOV-1997 was vaccinated with the first dose of VARIVAX vaccine (Oka/Merck) (route nor reported). On 18-JUL-2008 the patient was vaccinated with the second dose of VARIVAX vaccine (Oka/Merck) (lot number 659612/1655U) (route not reported) into the right triceps. On 27-OCT-2008 the patient developed some spots on stomach and on the back of both legs. The patient had a headache and no fever. The patient was diagnosed with varicella. On 03-NOV-2008, the patient recovered from varicella. Additional information is not expected.
Age: 16.0
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster, Incorrect route of drug administration, Pain, Rash, Rash vesicular
Clinical narrative: Information has been received form a physician concerning a 14 year old male with a history of attention deficit/hyperactivity disorder and possibly had chickenpox, who on 07-OCT-2008 was vaccinated with VARIVAX vaccine (Oka/Merck) (lot # 660408/0273X). On 13-OCT-2008 the patient came back and diagnosed with shingles (classic dermatome rash). ). The patient was prescribed MOTRIM for the day time and TYLENOL and codeine (manufacturer unspecified) for the night time for the discomfort. The mother of the patient thinks he may had chickenpox previously; however the physician's office could not confirm that. The patient sought unspecified medical attention. Follow up information was received from the doctor of osteopathy who reported that the patient was a 17 year old male student with no pre-existing allergies, birth defects and medical conditions. At 4 PM of 07-OCT-2008 the patient was vaccinated intramuscularly in his left deltoid with a first dose of VARIVAX vaccine (Oka/Merck) (lot # 660408/0273X). On 08-OCT-2008 the patient experienced painful vesicular rash on the right side of Chest. On 13-OCT-2008 the patient went to the office and was diagnosed with shingles. On 30-OCT-2008 the patient recovered. Additional information is not expected.
Age: 1.3
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Erythema, Nasal congestion, Rash papular, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 39 month old female with no medical history, no known allergies who on 10-OCT-2006 was vaccinated with the first dose of VARIVAX (Merck). The registered nurse reported that on 21-OCT-2008 the patient had a 2-3 day history of stuffy nose, no cough, no fever. The patient developed 10 red papules, some vesicles, no pustules. The patient recovered. The registered nurse reported the the patient experienced chicken pox on 21-OCT-2008. No lab/diagnostic tests were performed. There was no illness at the time of vaccination. No further information is available.
Sex: U
Vaccine: VARCEL, VARZOS
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a registered pharmacist concerning a patient who on 07-OCT-2008 was vaccinated subcutaneously with a 0.5 mL dose of VARIVAX (Oka/Merck) instead of ZOSTAVAX (Oka/Merck), due to pharmacy error.  No adverse effect was reported.  It is unknown if the patient sought medical attention.  Follow up information was received from the pharmacist who indicated that she did not want to provide additional information because the situation "has been taken care of".  No further information is available.
Age: 66.0
Sex: F
Vaccine: VARCEL, VARZOS
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a registered pharmacist concerning of a 66 years old white female who on 10-Nov-2008 was vaccinated with VARIVAX (Oka/Merck) (lot# 654409/1148X) instead of ZOSTAVAX (Oka/Merck), due to human error at the physician's office. No adverse effects were noted. The patient sought medical attention through an office visit. Follow up information has been received from a registered nurse who indicated that on 10-Nov-2008, the patient received the second dose of VARIVAX (Oka/Merck), SQ (lot #663198/1419X). Further information is not expected.
Age: 65.0
Sex: U
Vaccine: VARCEL, VARZOS
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from nurse concerning a patient who came into office to receive a dose of ZOSTAVAX (Merck) (MSD) but was given a dose of VARIVAX (Merck) "by mistake". No adverse effects reported as a result. Follow-up information received from the nurse. She reported that the medication error was a human error. Additional information has been requested.
Age: 0.6
Sex: M
Vaccine: VARCEL
Symptoms: Rash generalised, Scab
Clinical narrative: Information has been received from a physician concerning a 3 year old male who at the age of 7 months (in approximately 2005) was vaccinated with VARIVAX (Merck). Subsequently the patient experienced generalized rash about 10 days after his pregnant mother had developed a generalized rash. The patient was enrolled in the Varicella Zoster Virus Identification Program to identify if VZV is present and if it is present to identify if it is associated with the wild-type (WT) VZV strain or with the OKA/Merck vaccine VZV strain. Follow up information was received through the Varicella Zoster Virus (VZV) identification program which reported that there was odd looking "scabs" on the patient. The sample was inadequate. This is one of two reports from the same source. Additional information has been requested.
Age: 16.0
Sex: F
Vaccine: VARCEL
Symptoms: Abnormal behaviour, Agitation, Blood pressure increased, Bowel movement irregularity, Diet refusal
Clinical narrative: Information has been received from a pharmacist concerning a 16 year old female with penicillin allergy and a history of Guillain-Barre syndrome and autism who was vaccinated with a first and second dose of VARIVAX (Merck) 0.5ml subcutaneously on 04-APR-2006 (lot number: 659529/1590U) and 08-APR-2008, respectively. Concomitant therapy included CELEXA and gabapentin. The patient developed generalized pain, agitation, urinary retention and urinary frequency about 10 days after receiving a dose of VARIVAX (Merck) on 08-APR-2008. The patient's generalized pain, agitation, urinary retention and urinary frequency persisted. No other information was available at this time. Follow-up information has been received from a consumer concerning her daughter with penicillin allergy and a history of Guillain-Barre-like syndrome in fall 2007 and autistic who on 08-APR-2008 was vaccinated with VARIVAX (Merck) (route not reported). Concomitant therapy included CELEXA, gabapentin, RISPERDAL, ZANTAC and MOTRIN. After receiving the vaccine the patient experienced behavioral changes, extreme sensitivity touch and pain. She was unable to tolerate wearing clothes, refused to get in her wheelchair, and would not get out of bed. She would not allow anything to touch her skin. She also had an increase in her heart rate and blood pressure which required medication. She was unable to move her extremities or trunk area. She experienced increases in her urination frequency but with small amounts of urine each time. She was unable to have a bowel movement and would "dig out her feces". She was eating most foods but receiving medication via gastric feeding tube prior to receiving her second dose of VARIVAX (Merck). After receiving second dose of VARIVAX (Merck) she refused to eat. She had to be transported twice by ambulance to the hospital because of problems with the gastric feeding tube but was not admitted either time. The first dose of VARIVAX (Merck) was administered when she was younger but the date was not known. Presently the patient's symptoms have improved except for her lower legs and feet. Follow-up information received from the pharmacist indicated that the patient also had a medical history of asthma, anxiety and polyneuropathy acute inflammatory demyelinating. The patient's mother noticed that the patient refuse to wear her diaper and clothes a few weeks after vaccination. The patient would only sleep without sheets. The patient's psychiatrist started treating the patient for nerve pain and the patient's mother thought the patient was in pain. The patient developed rash on body looked like chickenpox. The patient's rash was not reported to the physician. The patient still had rash on buttocks and thighs and under arm going down toward waist with red marks. Per the mother, she was unable to lift the patient or get her in her wheelchair. The patient did not recover. Additional information is not expected.
Age: 16.0
Sex: F
Vaccine: VARCEL
Symptoms: Heart rate increased, Hyperaesthesia, Hypokinesia, Neuralgia, Pain
Clinical narrative: Information has been received from a pharmacist concerning a 16 year old female with penicillin allergy and a history of Guillain-Barre syndrome and autism who was vaccinated with a first and second dose of VARIVAX (Merck) 0.5ml subcutaneously on 04-APR-2006 (lot number: 659529/1590U) and 08-APR-2008, respectively. Concomitant therapy included CELEXA and gabapentin. The patient developed generalized pain, agitation, urinary retention and urinary frequency about 10 days after receiving a dose of VARIVAX (Merck) on 08-APR-2008. The patient's generalized pain, agitation, urinary retention and urinary frequency persisted. No other information was available at this time. Follow-up information has been received from a consumer concerning her daughter with penicillin allergy and a history of Guillain-Barre-like syndrome in fall 2007 and autistic who on 08-APR-2008 was vaccinated with VARIVAX (Merck) (route not reported). Concomitant therapy included CELEXA, gabapentin, RISPERDAL, ZANTAC and MOTRIN. After receiving the vaccine the patient experienced behavioral changes, extreme sensitivity touch and pain. She was unable to tolerate wearing clothes, refused to get in her wheelchair, and would not get out of bed. She would not allow anything to touch her skin. She also had an increase in her heart rate and blood pressure which required medication. She was unable to move her extremities or trunk area. She experienced increases in her urination frequency but with small amounts of urine each time. She was unable to have a bowel movement and would "dig out her feces". She was eating most foods but receiving medication via gastric feeding tube prior to receiving her second dose of VARIVAX (Merck). After receiving second dose of VARIVAX (Merck) she refused to eat. She had to be transported twice by ambulance to the hospital because of problems with the gastric feeding tube but was not admitted either time. The first dose of VARIVAX (Merck) was administered when she was younger but the date was not known. Presently the patient's symptoms have improved except for her lower legs and feet. Follow-up information received from the pharmacist indicated that the patient also had a medical history of asthma, anxiety and polyneuropathy acute inflammatory demyelinating. The patient's mother noticed that the patient refuse to wear her diaper and clothes a few weeks after vaccination. The patient would only sleep without sheets. The patient's psychiatrist started treating the patient for nerve pain and the patient's mother thought the patient was in pain. The patient developed rash on body looked like chickenpox. The patient's rash was not reported to the physician. The patient still had rash on buttocks and thighs and under arm going down toward waist with red marks. Per the mother, she was unable to lift the patient or get her in her wheelchair. The patient did not recover. Additional information is not expected.
Age: 16.0
Sex: F
Vaccine: VARCEL
Symptoms: Pollakiuria, Rash vesicular, Urinary retention
Clinical narrative: Information has been received from a pharmacist concerning a 16 year old female with penicillin allergy and a history of Guillain-Barre syndrome and autism who was vaccinated with a first and second dose of VARIVAX (Merck) 0.5ml subcutaneously on 04-APR-2006 (lot number: 659529/1590U) and 08-APR-2008, respectively. Concomitant therapy included CELEXA and gabapentin. The patient developed generalized pain, agitation, urinary retention and urinary frequency about 10 days after receiving a dose of VARIVAX (Merck) on 08-APR-2008. The patient's generalized pain, agitation, urinary retention and urinary frequency persisted. No other information was available at this time. Follow-up information has been received from a consumer concerning her daughter with penicillin allergy and a history of Guillain-Barre-like syndrome in fall 2007 and autistic who on 08-APR-2008 was vaccinated with VARIVAX (Merck) (route not reported). Concomitant therapy included CELEXA, gabapentin, RISPERDAL, ZANTAC and MOTRIN. After receiving the vaccine the patient experienced behavioral changes, extreme sensitivity touch and pain. She was unable to tolerate wearing clothes, refused to get in her wheelchair, and would not get out of bed. She would not allow anything to touch her skin. She also had an increase in her heart rate and blood pressure which required medication. She was unable to move her extremities or trunk area. She experienced increases in her urination frequency but with small amounts of urine each time. She was unable to have a bowel movement and would "dig out her feces". She was eating most foods but receiving medication via gastric feeding tube prior to receiving her second dose of VARIVAX (Merck). After receiving second dose of VARIVAX (Merck) she refused to eat. She had to be transported twice by ambulance to the hospital because of problems with the gastric feeding tube but was not admitted either time. The first dose of VARIVAX (Merck) was administered when she was younger but the date was not known. Presently the patient's symptoms have improved except for her lower legs and feet. Follow-up information received from the pharmacist indicated that the patient also had a medical history of asthma, anxiety and polyneuropathy acute inflammatory demyelinating. The patient's mother noticed that the patient refuse to wear her diaper and clothes a few weeks after vaccination. The patient would only sleep without sheets. The patient's psychiatrist started treating the patient for nerve pain and the patient's mother thought the patient was in pain. The patient developed rash on body looked like chickenpox. The patient's rash was not reported to the physician. The patient still had rash on buttocks and thighs and under arm going down toward waist with red marks. Per the mother, she was unable to lift the patient or get her in her wheelchair. The patient did not recover. Additional information is not expected.